This inventor holds 1 USPTO granted patent. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Eric D. Bischoff: Innovator in Breast Cancer Treatment
Introduction
Eric D. Bischoff is a notable inventor based in Encinitas, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of anti-estrogen resistant breast cancer. His innovative work has the potential to impact many lives.
Latest Patents
Eric D. Bischoff holds a patent for "Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators." This patent focuses on methods and compositions that utilize retinoid compounds, which are modulators of Retinoid X Receptors, to treat this challenging form of breast cancer. He has 1 patent to his name.
Career Highlights
Eric is currently associated with Ligand Pharmaceuticals, Inc., a company known for its commitment to advancing health through innovative therapies. His work at Ligand Pharmaceuticals has allowed him to explore new avenues in cancer treatment and contribute to the development of effective pharmaceutical solutions.
Collaborations
Throughout his career, Eric has collaborated with esteemed colleagues, including William W. Lamph and Richard Alan Heyman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Eric D. Bischoff's contributions to the field of breast cancer treatment exemplify the impact of innovative thinking in pharmaceuticals. His work continues to inspire advancements in medical science and offers hope for patients facing challenging health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile